ScholarWorks@SUNGKYUNKWAN UNIVERSITY: SUNG, KI WOONG

Detailed Information

SUNG, KI WOONG (성기웅)

Medicine (Medicine)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Neuroblastoma:19||Children:14||neuroblastoma:12||highdose chemotherapy:9||Highdose chemotherapy:8||children:8||Prognosis:7||Survival:6||Mesenchymal stem cell:6||Child:5||autologous stem cell transplantation:5||Hematopoietic stem cell transplantation:4||prognosis:4||MYCN:4||hematopoietic stem cell transplantation:4||Radiotherapy:4||chemotherapy:4||HighDose Chemotherapy:4||Autologous Stem Cell Transplantation:4||Highdose Chemotherapy:4||Cell therapy:4||Relapse:3||child:3||Mesenchymal stem cells:3||Cyclophosphamide:3||Childhood:3||Cytomegalovirus:3||TRAIL:3||Autologous stem cell transplantation:3||Korea:3||Fludarabine:3||Allogeneic hematopoietic stem cell transplantation:3||Brain neoplasms:3||Cord blood transplantation:3||Cell density:2||medulloblastoma:2||mesenchymal stem cells:2||metastasis:2||Pneumococcus:2||minimal residual disease:2||Korean:2||Korean children:2||Health behavior:2||Leukemia:2||osteosarcoma:2||Brain Tumor:2||Prognostic factor:2||Hematopoietic cell transplantation:2||Diamond blackfan anemia:2||Brain tumor:2||prognostic factor:2||Hib:2||RTPCR:2||cell density:2||radiation therapy:2||Breast cancer:2||cisplatin:2||Chemotherapy:2||Medulloblastoma:2||Allogeneic Hematopoietic Stem Cell Transplantation:2||CXCR7:2||tyrosine hydroxylase:2||Apoptosis:2||Severe aplastic anemia:2||Allogeneic stem cell transplantation:2||Solid Tumor:2||Childhood cancer survivors:2||Nmyc:2||Stem cell transplant:2||Stem cell transplantation:2||Nmyc protooncogene protein:2||Cancer survivors:2||Neoplasm metastasis:2||Autologous:2||Chimerism:2||Neurotrophin3:2||Neutropenia:2||Acute lymphoblastic leukemia:2||Caregiver:2||Thymoglobulin:2||NonMalignant Disease:2||Toxicity:2||Transplantation:2||Transplantation, Autologous:2||Treatment:2||Indoleamine 2,3dioxygenase:2||TrkC:2||Genomewide association study:2||Infant:2||Congenital defects:2||Anemia:2||Germinoma:2||Umbilical cord blood:2||Unrelated donor:2||Vaccination:2||Acute myeloid leukemia:2||Vanillylmandelic acid:2||Peripheral Blood Stem Cell Collection:2||Wilms tumor:2||Peroxisome proliferatoractivated receptor gamma:2||High risk:1||Highdose I131MIBG:1||Highgrade Glioma:1||Hodgkin Lymphoma:1||Homovanillic acid:1||Human calicivirus:1||Human chorionic gonadotropin:1||Hypervascular hepatic nodule:1||Hypoxia:1||I131metaiodobenzylguanidine treatment:1||IFNgamma:1||Idarubicin:1||Immunocompromised host:1||Immunohistochemistry:1||Immunomodulation:1||Immunosuppression:1||Immunotherapy:1||Induction:1||Influenza:1||Inhibitor of Apoptosis Protein:1||Injured tissues:1||Integrated diagnosis:1||Interferongamma:1||Intracranial germ cell tumor:1||KasabachMerritt syndrome:1||Kidney neoplasms:1||Langerhans cell histiocytosis:1||Late Complication:1||Leukemia, Myeloid, Acute:1||Leukemic cells:1||Local co:1||Longterm Followup Care:1||Loss of heterozygosity:1||Low dose cytarabine:1||Lymphocyte:1||MIBG:1||MYCN Amplification:1||MYCN amplification:1||MYCN nonamplified neuroblastoma:1||Mass spectrometry:1||Mediastinum:1||Mesenchym:1||Metabolic syndrome:1||Migration:1||Molecular subgroup:1||Monosomal karyotype:1||Mutation:1||Mutational signature:1||Myelodysplastic syndrom:1||Myeloid:1||NFkappa B:1||NOTCH1:1||Neoplasms. Germ Cell and Embryonal:1||Neuroblastoma:1||Neurologic complication:1||Neutropenic fever:1||New York protocol:1||Norovirus:1||Oligonucleotide therapy:1||Outcome:1||Parent caregivers:1||Parenting stress:1||Pediatric Hematologists/Oncologists:1||Pediatric ependymomas:1||Pediatric hematopoietic stem cell transplantation:1||Pediatric population:1||Photon beam therapy:1||Physical activity:1||Platelet:1||Polymerase Chain Reaction:1||Polymerase chain reaction:1||Postremission therapy:1||Preengraftment syndrome:1||Preferences:1||Primary immune deficiency:1||Progenitor cells:1||Prognostic markers:1||Progressive hemiparesis:1||Prostaglandin E synthase:1||Prostaglandin E2:1||Proton beam therapy:1||QuantiferonCMV:1||RAD001 (everolimus):1||RNAi:1||Radiation Therapy:1||Recurrence:1||Reducedintensity conditioning:1||Response:1||Risk stratification:1||Second Neoplasm:1||Sedentary behavior:1||Seeding density:1||Segmental Chromosomal Aberration:1||Sequelae:1||Sequencing:1||Seropositive:1||Serum DNA:1||Severe combined immunodeficiency:1||Short tandem repeats:1||Smoking:1||Stem cell donor:1||Stem cells:1||Stemness:1||Stereotactic biopsy:1||Survivors:1||Survivors of childhood cancer:1||T cell acute lymphoblastic leukemia:1||Tcell immunity:1||TNFalpha:1||Tandem:1||Therapyrelated myeloid neoplasms:1||Therapyrelated neoplasms:1||Thorax:1||Total Body Irradiation:1||Treatment outcome:1||Tumour mutation burden:1||Tyrosine 3monooxygenase:1||UL54 protein:1||UNC13D:1||URD HSCT:1||Unmet needs:1||Urine:1||Validation:1||Varicella zoster virus:1||XLinked Inhibitor of Apoptosis Protein:1||Young Adult:1||acute myeloid leukemia:1||adipose tissue:1||adjuvant therapy:1||allogeneic hematopoietic cell transplantation:1||amikacin:1||anaplastic ependymoma:1||aplastic anemia:1||apoptosis:1||attention problems:1||autoSCT:1||autologous peripheral blood stem cells:1||autologous stem cell rescue:1||autologous transplantation:1||benign liver neoplasms:1||bilateral retinoblastoma:1||bone marrow:1||bone marrow transplantation:1||breast cancer:1||cancer survivors:1||caspase8:1||cefepime:1||cell expansion:1||chemoreduction:1||childhood brain cancer:1||clinical relevance:1||colonyforming unitsgranulocyte/macrophage (CFUGM):1||complete remission:1||cord blood transplantation:1||craniospinal radiotherapy:1||culture condition:1||cyclophosphamide:1||cytogenetics:1||cytokine:1||cytomegalovirus:1||death receptor:1||depression:1||docetaxel:1||double unit:1||drug resistance:1||efficacy:1||empirical therapy:1||engraftment:1||epidemiology:1||externalbeam radiation therapy:1||familial:1||febrile neutropenia:1||ferritin:1||firef:1||fluorescence in situ hybridization (FISH):1||focal nodula:1||galactomannan antigen assay:1||ganciclovir kinase:1||gemcitabine:1||genetics:1||genotype:1||glomerular function:1||gross residual tumor:1||haploidentical stem cell transplantation:1||heathrelated quality of life:1||hematopoietic stem cell transplant:1||hematopoietic stem cells:1||hematopoietic transplantation:1||hemophagocytic histiocytosis:1||hemophagocytic lymphohistiocytosis:1||high risk:1||highdose ch:1||highrisk neuroblastoma:1||human adenovirus:1||injured tissues:1||intelligence:1||interstitial lung disease:1||intrabone marrow transplantation:1||invasive as:1||invasive aspergillosis:1||killer immunoglobulinlike receptor:1||late effects:1||leukemia:1||ligand:1||lipid microspherescontaining prostaglandin E1:1||longterm followup:1||longterm outcome:1||maturation:1||metaiodobenzylguanidi:1||microRNA145:1||migration:1||multipl:1||neuronal apoptosis inhibitory protein (NAIP):1||nextgeneration sequencing (NGS):1||nonHod:1||nosocomial infection:1||outcome:1||pancreas, metastasis:1||parainfluenza virus:1||parenting stress:1||pediatr:1||pediatric cancer:1||pegteograstim:1||peripheral blood:1||permanent consequence:1||predominating unit:1||primary immunodeficiency:1||proliferation activity:1||prophylaxis:1||prospective longitudinal study:1||quality of life:1||reactivation:1||recurrent:1||refractory:1||relapse:1||safety:1||segmental chromosomal aberration (SCA):1||sequencing:1||social relationships:1||solid tumors:1||stem cell transplantation:1||supratentorial primitive neuroectodermal tumor:1||survival:1||tandem highdose chemotherapy:1||tandem transplant:1||therapeutic drug mo:1||thiopurine methyltransferase:1||treatmentrelated mortality:1||tubular function:1||umbilical cord blood:1||unrelated donor hematopoietic stem cell transplantation:1||vaccination:1||venoocclusive disease:1||(11)CMethionine positron emission tomography:1||virus type:1||11q deletion:1||16q:1||17q gain:1||1p:1||1p deletion:1||ADL:1||ALK:1||AML:1||ARID1B:1||ATRT:1||Absolute neutrophil count recovery:1||Acute:1||Acute Leukemia:1||Adenovirus:1||Adipose tissue stem cell:1||Adolescent:1||Adverse effects:1||Age:1||Alcohol drinking:1||Anaplastic lymphoma kinase:1||Antileukemic effect:1||Antithymocyte globulin (ATG):1||Artificial intelligence:1||Au:1||Autologous Stem Cell Rescue:1||Autologous Stem Cell Trans:1||Autologous hematopoietic cell transplantation:1||Autologous stem cell transplantation.:1||Bacteremia:1||Basal ganglia:1||Biological characteristics:1||Bmi1:1||Body composition:1||Bone Marrow Tumors:1||Bone and Soft Tissue Sarcoma:1||Bone and soft tissue sarcoma:1||Bone marrow sample:1||CD34+cells:1||Calcineurin inhibitor:1||Cancer:1||Cancer survivor:1||Carboplatin:1||Cardiac function:1||Caregivers:1||Cell count:1||Cell cycle regulator:1||Cell dose:1||Cell proliferation:1||Central Nervous System:1||Central nervous system germ cell tumor:1||Cerebral hemiatrophy:1||Childhood Cancer Survivorship:1||Childhood brain tumor:1||Childhood brain tumors:1||Childhood cancer sur:1||Childhood cancer survivor:1||Childhood cancer survivorship care:1||Children and adolescents:1||Chimerism analyses:1||Comprehensive needs assessment tool for cancer caregivers:1||Cord Blood Transplantation:1||Cord blood transplantati:1||Craniospinal irradiation:1||Culture time:1||Cyclooxygenase 2:1||Cytokine:1||Death receptor:1||Deep learning model:1||Double units:1||Down syndrome:1||Drug Therapy:1||ERK2:1||Echocardiography:1||Engraftment:1||Enocitabine:1||Epidemiology:1||Exercise:1||FHL:1||FHL3:1||Familial:1||Fat percentage:1||Firefly luciferase:1||Gene:1||Gene expression pattern:1||Genetic variation:1||Genomic profile:1||Germ cell and embryonal neoplasms:1||Germline:1||Graftversushost disease:1||Graftversustumor effect:1||HLA:1||HRQOL:1||Haploidentical stem cell transplantation:1||Hematological outcome:1||Hematopoietic Stem Cell Transplantation:1||Hematopoietic stem cell:1||Hemoglobin:1||Hemophagocytic lymphohistiocytosis:1||Herpes zoster:1||

STATISTICS: Total View :0; Today View :4,349

RSS_1.0 RSS_2.0 ATOM_1.0

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREAsamsunglib@skku.edu

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE